Early research (Phase 1)Looking for participantsNCT05603910
What this trial is testing
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
Who this might be right for
Recurrent Endometrial CarcinomaUnresectable Endometrial Carcinoma
Aaron Wolfson 18